Stephen Mark Cone's most recent trade in biote Corp - Ordinary Shares - Class A was a trade of 104,547 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 104,547 | 104,547 | - | - | Stock Option (Right to Buy) | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 17,989 | 38,341 | - | - | Deferred Settlement RSU | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 17 Mar 2025 | 38,104 | 160,829 | - | 3.9 | 147,844 | Class A Common Stock |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 65,258 | 143,763 | - | - | Stock Option (Right to Buy) | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 10,828 | 20,352 | - | - | Deferred Settlement RSU | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 6,058 | 0 | - | - | Phantom Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 6,058 | 122,725 | - | - | Class A Common Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 46,809 | 78,505 | - | - | Stock Option (Right to Buy) | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 9,524 | 9,524 | - | - | Deferred Settlement RSU | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 9,844 | 116,667 | - | - | Class A Common Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 9,844 | 6,058 | - | - | Phantom Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 09 Jan 2023 | 83,350 | 106,823 | - | 3 | 250,050 | Class A Common Stock |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 9,844 | 15,902 | - | - | Phantom Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 9,844 | 23,473 | - | - | Class A Common Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 31,696 | 31,696 | - | - | Stock Option (Right to Buy) | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 13,629 | 25,746 | - | - | Phantom Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 13,629 | 13,629 | - | - | Class A Common Stock | |
| biote Corp - Ordinary Shar... | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 39,375 | 39,375 | - | - | Phantom Stock |